🚨 Windtree: from Nasdaq to OTC and the bet on $BNB
The biotech Windtree Therapeutics (WINT) is in the eye of the storm 🔥
🔻 Delisting from Nasdaq
On August 19, Nasdaq notified its delisting for failing to comply with the minimum price rule of USD 1.
On August 21, its listing was suspended and it will now move to OTC Markets.
📉 Brutal drop of the stock
The price plummeted nearly 80%, reaching only USD 0.11.
Lower liquidity, less transparency, and extra risk for investors.
💰 The controversial play with BNB
In July, they announced a treasury strategy with Binance Coin (BNB) and agreements for up to USD 200M+.
They even partnered with Kraken for custody and trading.
But the market didn't buy the idea and the collapse was swift.
🔬 Biotech context
Many small biotechs suffer delistings due to lack of stable income.
Windtree tried to "innovate" with crypto, but the play turned out to be costly.
👉 Do you think this strategy with BNB was forward-thinking or a desperate gamble? 🤔
